Foundation Briefing on Capitol Hill Draws Crowd
| 1 min read

Breathing New Life Into Venture Philanthropy

Speakers included: Robert J. Beall, Ph.D., president and CEO of the CF Foundation; Joshua Boger, Ph.D., president and CEO of Vertex Pharmaceuticals; and Pamela L. Zeitlin, M.D., Ph.D., co-director of the CF Center at Johns Hopkins University Hospital. They highlighted the CF Foundation's pioneering collaborative approach with private sector programs, which has set a new standard for investment in life-saving research.

"We changed the paradigm," said Beall at the event. "As a result, we have created a pipeline of nearly 30 products for the treatment of CF. We have introduced new therapies that have a profound impact on the quality of life for cystic fibrosis patients."

The CF Foundation is grateful to the Congressional Cystic Fibrosis Caucus and its co-chairs, Reps. Edward Markey (D-MA) and Cliff Stearns (R-FL), for hosting this briefing. With more than 100 members of Congress, the CF Caucus' mission is to educate elected officials about cystic fibrosis and spur action on issues that concern the CF community.

To get involved in the CF Foundation's advocacy efforts, contact

Share this article
About the CF Foundation | Public Policy | Advocacy
Recent news
CF Foundation Establishes Health Equity Awards to Advance Research Toward Optimal Health Outcomes
News | 5 min read
CF Foundation Honors the Legacy of Joe O’Donnell
News | 4 min read
CF Foundation Invests up to $5M in Clarametyx Biosciences to Develop a New Anti-Bacterial Therapy 
News | 2 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.